Antiva Biosciences
Stopping Cancer Before It Starts
- Headquarters
- South San Francisco, California
- Employees
- 11–50
- Founded
- 2012
- Business Model
- B2B
- Website
- antivabio.com
- Total Funding
- $121.0M
- Last Round
- $53.0M Series EApr 2023
About
Antiva Biosciences is a clinical-stage biopharmaceutical company developing novel topical therapeutics for the treatment of oncogenic HPV infections and pre-cancerous cervical lesions. Their lead therapy aims to give women a non-surgical, at-home treatment option — the first approved drug treatment for HPV infection — supporting the WHO's global Cervical Cancer Elimination Initiative.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account